Terazosin labels and packages: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 3: Line 3:
{{CMG}}; {{AE}} {{AK}}
{{CMG}}; {{AE}} {{AK}}


==Labels And PAckages==
==Labels And Packages==
PRINCIPAL DISPLAY PANEL TERAZOSIN HYDROCHLORIDE CAPSULES 1 MG
PRINCIPAL DISPLAY PANEL TERAZOSIN HYDROCHLORIDE CAPSULES 1 MG


Line 29: Line 29:


<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = TERAZOSIN HYDROCHLORIDE CAPSULE [CARDINAL HEALTH] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=30503dfd-03bd-46d8-8170-d9ed096fd71d | publisher =  | date =  | accessdate = 7 March 2014 }}</ref>
<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = TERAZOSIN HYDROCHLORIDE CAPSULE [CARDINAL HEALTH] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=30503dfd-03bd-46d8-8170-d9ed096fd71d | publisher =  | date =  | accessdate = 7 March 2014 }}</ref>


==References==
==References==

Revision as of 19:40, 12 March 2014

Terazosin
Terazosin®, Hytrin® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings
Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Terazosin
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]

Labels And Packages

PRINCIPAL DISPLAY PANEL TERAZOSIN HYDROCHLORIDE CAPSULES 1 MG

Terazosin Hydrochloride

Capsules 1 mg.*

10 Capsules

PRINCIPAL DISPLAY PANEL TERAZOSIN HYDROCHLORIDE CAPSULES 5 MG

Terazosin Hydrochloride

Capsules 5 mg.*

10 Capsules

[1]

References

  1. "TERAZOSIN HYDROCHLORIDE CAPSULE [CARDINAL HEALTH]". Retrieved 7 March 2014.